Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the combination of Taxotere and exisulind is an
effective and safe treatment for patients with advanced NSCLC who have failed a prior
platinum-containing regimen.